Stock Quote        
  Join        Login  
logo

Intuitive Surgical (ISRG) Earnings Preview

 January 22, 2013 12:08 AM
 

(By Balachander) Intuitive Surgical Inc. (NASDAQ: ISRG) is expected to post an increase in fourth-quarter earnings spurred by sales growth of its robotic surgical systems.

Wall Street analysts, on average, expect ISRG's earnings per share to increase 9.6 percent to $4.11 on revenue growth of 17.50 percent to $584 million for the three month period.

Sunnyvale, California-based Intuitive Surgical, which is engaged in in minimally invasive robotic surgery business, is scheduled to report its quarterly numbers on Jan.22.

For four straight quarters, Intuitive Surgical has posted double-digit revenue increases.

For the full year, the company is projected to earn $14.87 a share on revenue jumping 22.50 percent to $2.15 billion.

During the last month, three analysts have recommended ISRG as "Strong Buy" and five analysts gave "Buy" rating,  while seven analysts gave "Hold" rating on the stock. There is no analyst to recommend "Sell" on the stock.

In the preceding third quarter, the company posted a 50 percent jump in earnings as continued adoption of da Vinci surgery procedures and higher da Vinci Surgical System sales drove revenue growth of 20 percent.

A one-time tax benefit also boosted prior quarter results. The company earned $183 million or $4.46 a share on revenue of $538 million for the third quarter.

As of Sept. 30, 2012, the company noted there were 2,462 da Vinci Systems installed in over 1,936 hospitals worldwide. The company's da Vinci System allows surgeons to perform even complex procedures, like heart valve and cancer surgery. 

The stock has trading in the 52-week range of $429.26 to $594.89.


Rich
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.

You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.

Two Week FREE Trial


Signup for i on the market daily edition


Advertisement

Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

Advertisement
Connect with iStockAnalyst
Popular Articles
Recent Research and Quote
Advertisement
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.